These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 14638762)

  • 1. Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1.
    Singh S; Kennedy MC; Long CA; Saul AJ; Miller LH; Stowers AW
    Infect Immun; 2003 Dec; 71(12):6766-74. PubMed ID: 14638762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
    Darko CA; Angov E; Collins WE; Bergmann-Leitner ES; Girouard AS; Hitt SL; McBride JS; Diggs CL; Holder AA; Long CA; Barnwell JW; Lyon JA
    Infect Immun; 2005 Jan; 73(1):287-97. PubMed ID: 15618165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
    Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
    Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies.
    Pandey KC; Singh S; Pattnaik P; Pillai CR; Pillai U; Lynn A; Jain SK; Chitnis CE
    Mol Biochem Parasitol; 2002 Aug; 123(1):23-33. PubMed ID: 12165386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
    Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC
    Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.
    Hui GS; Nikaido C; Hashiro C; Kaslow DC; Collins WE
    Infect Immun; 1996 May; 64(5):1502-9. PubMed ID: 8613353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.
    Otsyula N; Angov E; Bergmann-Leitner E; Koech M; Khan F; Bennett J; Otieno L; Cummings J; Andagalu B; Tosh D; Waitumbi J; Richie N; Shi M; Miller L; Otieno W; Otieno GA; Ware L; House B; Godeaux O; Dubois MC; Ogutu B; Ballou WR; Soisson L; Diggs C; Cohen J; Polhemus M; Heppner DG; Ockenhouse CF; Spring MD
    Malar J; 2013 Jan; 12():29. PubMed ID: 23342996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum.
    Stowers AW; Chen Lh LH; Zhang Y; Kennedy MC; Zou L; Lambert L; Rice TJ; Kaslow DC; Saul A; Long CA; Meade H; Miller LH
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):339-44. PubMed ID: 11752405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.
    Stowers AW; Cioce V; Shimp RL; Lawson M; Hui G; Muratova O; Kaslow DC; Robinson R; Long CA; Miller LH
    Infect Immun; 2001 Mar; 69(3):1536-46. PubMed ID: 11179324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.
    Stowers AW; Kennedy MC; Keegan BP; Saul A; Long CA; Miller LH
    Infect Immun; 2002 Dec; 70(12):6961-7. PubMed ID: 12438375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains.
    Somner EA; Ogun SA; Sinha KA; Spencer Valero LM; Lee JJ; Harrison JA; Holder AA; Hormaeche CE; Khan ACM
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():221-229. PubMed ID: 10206702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women.
    Taylor DW; Zhou A; Marsillio LE; Thuita LW; Leke EB; Branch O; Gowda DC; Long C; Leke RF
    Infect Immun; 2004 Mar; 72(3):1603-7. PubMed ID: 14977967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate.
    Pizarro JC; Chitarra V; Verger D; Holm I; PĂȘtres S; Dartevelle S; Nato F; Longacre S; Bentley GA
    J Mol Biol; 2003 May; 328(5):1091-103. PubMed ID: 12729744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor.
    Kumar S; Villinger F; Oakley M; Aguiar JC; Jones TR; Hedstrom RC; Gowda K; Chute J; Stowers A; Kaslow DC; Thomas EK; Tine J; Klinman D; Hoffman SL; Weiss WW
    Immunol Lett; 2002 Apr; 81(1):13-24. PubMed ID: 11841841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR.
    Morgan WD; Lock MJ; Frenkiel TA; Grainger M; Holder AA
    Mol Biochem Parasitol; 2004 Nov; 138(1):29-36. PubMed ID: 15500913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
    Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
    Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B; Hundt E; Knapp B
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses.
    Lyon JA; Angov E; Fay MP; Sullivan JS; Girourd AS; Robinson SJ; Bergmann-Leitner ES; Duncan EH; Darko CA; Collins WE; Long CA; Barnwell JW
    PLoS One; 2008 Jul; 3(7):e2830. PubMed ID: 18665258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.